AMIFAMPRIDINE

✅ AMIFAMPRIDINE (CAS 54-96-6) – PRODUCT DESCRIPTION

Amifampridine (CAS 54-96-6) is an oral medication primarily used in the treatment of Lambert-Eaton Myasthenic Syndrome (LEMS), a rare autoimmune disorder that impairs neuromuscular transmission. By enhancing the release of acetylcholine at the neuromuscular junction, Amifampridine improves muscle strength and neuromuscular function in patients with LEMS. It is a white to off-white crystalline powder that is soluble in alcohol and used to increase the neurotransmitter release at nerve endings, improving communication between nerves and muscles. Amifampridine is crucial for clinical treatment of LEMS and is used in research to study neuromuscular diseases and explore new treatment options. We supply Amifampridine in pharmaceutical, research, and clinical grades, ensuring high-quality standards for global distribution to USA, Malaysia, Vietnam, and Chile.

📦 Industries Used In:

• Pharmaceuticals (treatment of Lambert-Eaton Myasthenic Syndrome (LEMS))

• Healthcare (improving neuromuscular transmission in patients)

• Research (studies on neuromuscular diseases and neurotransmission mechanisms)

• Clinical Trials (investigating potential treatments for neuromuscular disorders)

🧪 Available Grades:

• Pharmaceutical Grade

• Research Grade

• Clinical Grade

⚙️ Functions:

• Increases acetylcholine release at the neuromuscular junction, improving muscle strength in LEMS patients

• Treats neuromuscular disorders by enhancing neuromuscular transmission

• Used in research to study the mechanisms of neuromuscular diseases

• Investigates potential therapeutic applications for neuromuscular conditions

• Clinical use in the treatment of Lambert-Eaton Myasthenic Syndrome

🧩 Classified Under:

• Pharmaceuticals

• Neuromuscular Disorders

• Autoimmune Diseases

• Active Pharmaceutical Ingredients (APIs)

• Clinical Research